“☀막장판매합니다 텔레@MAG858 성난황소 연결시 5천테더드림 황소님 일좀 합시다. 부산100개 입니다.쉬었다가 일하려니 맞는사람이 없네요!☀”的搜索结果，显示 201-210 项，共有 13037 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 5], wearable Heel2Toe sensor technology and daily step count, and to estimate recruitment, retention, adherence, and acceptability rates. International ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Anticipated time on study is up to 5 years. Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young. Rochester, Minn. The aim of this study ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ... 5 separate tumor cohorts. The four cancer types are: Non-Small Cell Lung ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in ...